Recherche
-
Risk of first ischemic stroke and use of antidopaminergic antiemetics: A nationwide case-time-control study
(Fundamental and Clinical Pharmacology. vol. 36, pp. 22-23, 2022-06)Article de revue -
Les données du SAMU comme moyen de surveillance de la santé de la population
(Dataquitaine 2022 - 5e Journée Dataquitaine, Dataquitaine 2022 - 5e Journée Dataquitaine, fr, Talence, 2022-02-10)Communication dans un congrès avec actesLibre accès -
Risk factors for failed first intubation attempt in an out-of-hospital setting: a multicenter prospective study
(Internal and Emergency Medicine, 2022-10-19)Article de revue -
Particularités de la prise en charge des patients douloureux chronique aux urgences
(Douleurs : Évaluation - Diagnostic - Traitement. vol. 23, n° 1, pp. 31-36, 2022-02-13)Article de revue -
Surveillance of COVID-19 using a keyword search for symptoms in reports from emergency medical communication centers in Gironde, France: a 15 year retrospective cross-sectional study
(Internal and Emergency Medicine. vol. 17, pp. 1-6, 2022-03)Article de revue -
Comparison of two infant cardiopulmonary resuscitation techniques explained by phone in a non-health professionals' population: Two-thumbs encircling hand technique vs. two-fingers technique, a randomised crossover study in a simulation environment
(American Journal of Emergency Medicine. vol. 61, pp. 163-168, 2022-09-14)Article de revue -
Are patients with chronic pain less satisfied with their emergency room management than non-chronic pain patients?
(American Journal of Emergency Medicine. vol. 56, pp. 7-9, 2022-03-19)Article de revue -
The benefit of augmenting open data with clinical data-warehouse EHR for forecasting SARS-CoV-2 hospitalizations in Bordeaux area, France
(JAMIA open. vol. 5, n° 4, 2022-12)Article de revueLibre accès -
SurvMaximin: Robust federated approach to transporting survival risk prediction models
(Journal of Biomedical Informatics. vol. 134, 2022-08-23)Article de revue -
Association study between herpes zoster reporting and mRNA COVID‐19 vaccines (BNT162b2 and mRNA‐1273)
(British Journal of Clinical Pharmacology. vol. 88, n° 7, pp. 3529-3534, 2022-07)Article de revue